solid Q122 financials for $MEDI If those looking to invest in the ketamine therapy sector while it is still a budding industry I would recommend looking into KetamineOne ( $MEDI $KONEF ).
$MEDI recently released their financials for Q122 (which ended October 31st, 2021 for the company) and they were really promising.
Their total assets equated to $19.08M and the revenue made was $1. 99M which in the same quarter last year was $nil.
Similarly, gross profit in Q121 was $nil but it grew to $594k Q122.
If you're into investing in novel medication/drugs/treatment and/or psychedelics definitely check out $MEDI's full financials here: https://ca.finance.yahoo.com/news/ketamine-one-reports-strong-1q22-080000368.html
$MEDI @ $0.29, MC $29.971M